Data gathered: April 21
Alternative Data for Beyond Air
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 2 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 5,000 | Sign up | Sign up | Sign up |
| Google Trends | 62 | Sign up | Sign up | Sign up |
| Patents | 14 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 30 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 4,395 | Sign up | Sign up | Sign up |
| Twitter Followers | 473 | Sign up | Sign up | Sign up |
| Twitter Mentions | 8 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 75 | Sign up | Sign up | Sign up |
About Beyond Air
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system.
| Price | $0.23 |
| Target Price | Sign up |
| Volume | 308,870 |
| Market Cap | $21M |
| Year Range | $0.22 - $0.67 |
| Dividend Yield | 0% |
| Analyst Rating | 67% buy |
| Industry | Biotechnology |
In the news
Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at HomeApril 9 - GlobeNewswire |
|
Beyond Air Announces Vanderbilt University Medical Center as First Luminary SiteMarch 31 - GlobeNewswire |
|
 |
Pulse Biosciences (NASDAQ:PLSE) versus Beyond Air (NASDAQ:XAIR) Financial ReviewMarch 28 - ETF Daily News |
 |
Comparing Beyond Air (NASDAQ:XAIR) & Valeritas (OTCMKTS:VLRXQ)March 24 - ETF Daily News |
Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PHMarch 11 - GlobeNewswire |
|
 |
How Air New Zealand’s Sustainability Experiment May Make Flying GreenerApril 19 - Forbes |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 800,000 | 1.9M | -1.1M | -13M | -12M | -0.280 |
| Q2 '24 | 680,000 | 1M | -330,000 | -12M | -13M | -0.270 |
| Q1 '24 | 470,000 | 980,000 | -510,000 | -14M | -12M | -0.360 |
| Q4 '23 | 390,000 | 750,000 | -360,000 | -16M | -16M | -0.500 |
| Q3 '23 | 240,000 | 430,000 | -190,000 | -16M | -17M | -0.510 |
Insider Transactions View All
| Carey Robert filed to buy 4,076,864 shares at $0.3. March 17 '25 |
| Carey Robert filed to buy 4,066,864 shares at $0.3. March 17 '25 |
| Gaul Michael A. filed to buy 94,150 shares at $0.4. February 21 '25 |
| Carey Robert filed to buy 26,142 shares at $0. October 1 '24 |
| Lisi Steven A. filed to buy 506,321 shares at $0. October 1 '24 |
Similar companies
Read more about Beyond Air (XAIR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Beyond Air?
The Market Cap of Beyond Air is $21M.
What is the current stock price of Beyond Air?
Currently, the price of one share of Beyond Air stock is $0.23.
How can I analyze the XAIR stock price chart for investment decisions?
The XAIR stock price chart above provides a comprehensive visual representation of Beyond Air's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Beyond Air shares. Our platform offers an up-to-date XAIR stock price chart, along with technical data analysis and alternative data insights.
Does XAIR offer dividends to its shareholders?
As of our latest update, Beyond Air (XAIR) does not offer dividends to its shareholders. Investors interested in Beyond Air should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Beyond Air?
Some of the similar stocks of Beyond Air are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.